Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Kathleen Torkko

Concepts (290)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
19
2021
1016
1.690
 Why?
Prostate
6
2024
179
0.950
 Why?
Vitamin D
4
2020
385
0.810
 Why?
Adenocarcinoma
5
2020
898
0.660
 Why?
Biopsy
7
2019
1092
0.570
 Why?
Prostatic Hyperplasia
1
2015
42
0.460
 Why?
Breast Neoplasms
9
2024
2140
0.440
 Why?
Receptors, Androgen
4
2021
147
0.430
 Why?
Finasteride
3
2024
37
0.420
 Why?
B7-1 Antigen
6
2010
61
0.420
 Why?
Polymorphism, Single Nucleotide
1
2020
2063
0.390
 Why?
Biomarkers, Tumor
9
2019
1173
0.320
 Why?
Estrogen Receptor alpha
3
2020
133
0.320
 Why?
3-Oxo-5-alpha-Steroid 4-Dehydrogenase
1
2008
8
0.300
 Why?
Genetic Predisposition to Disease
3
2020
2276
0.290
 Why?
Receptors, Calcitriol
1
2008
54
0.290
 Why?
Polymorphism, Genetic
2
2008
639
0.290
 Why?
Phenylthiohydantoin
3
2021
44
0.280
 Why?
Tamoxifen
4
2016
199
0.280
 Why?
Immunohistochemistry
11
2019
1691
0.250
 Why?
Inflammation
2
2015
2737
0.250
 Why?
Doxazosin
1
2024
3
0.230
 Why?
Prostatic Diseases
1
2024
5
0.230
 Why?
Biomarkers
2
2015
3968
0.230
 Why?
Endometrium
4
2008
60
0.220
 Why?
Receptors, Estrogen
5
2017
426
0.220
 Why?
Triple Negative Breast Neoplasms
2
2017
197
0.210
 Why?
Aged, 80 and over
11
2020
7055
0.210
 Why?
Bone Morphogenetic Proteins
1
2024
130
0.210
 Why?
Aged
22
2020
22032
0.200
 Why?
5-alpha Reductase Inhibitors
2
2020
16
0.200
 Why?
Ovarian Neoplasms
4
2010
489
0.190
 Why?
Middle Aged
25
2020
31091
0.190
 Why?
Bone Neoplasms
1
2024
231
0.180
 Why?
MAP Kinase Kinase Kinases
1
2021
71
0.180
 Why?
Precancerous Conditions
3
2010
163
0.170
 Why?
Risk
3
2020
854
0.170
 Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2020
18
0.170
 Why?
Medical History Taking
1
2000
119
0.170
 Why?
Cell Line, Tumor
9
2021
3202
0.170
 Why?
Humans
47
2024
129271
0.170
 Why?
Chlamydia Infections
1
2000
73
0.160
 Why?
DNA Helicases
1
2021
149
0.160
 Why?
Antineoplastic Agents, Hormonal
3
2014
157
0.160
 Why?
Macrophages
3
2024
1484
0.160
 Why?
Neoplasm Proteins
2
2016
422
0.160
 Why?
RNA Interference
1
2021
450
0.160
 Why?
Metabolic Networks and Pathways
1
2020
178
0.150
 Why?
Carcinoma, Endometrioid
3
2008
47
0.150
 Why?
Euterpe
1
2018
5
0.150
 Why?
Lymphocytes, Tumor-Infiltrating
3
2018
207
0.150
 Why?
Disease Progression
5
2018
2630
0.150
 Why?
Physicians, Family
1
2000
207
0.150
 Why?
Male
25
2021
63517
0.150
 Why?
Tryptophan Oxygenase
1
2018
35
0.150
 Why?
Uterine Cervical Dysplasia
2
2010
42
0.150
 Why?
Drug Resistance, Neoplasm
3
2021
756
0.150
 Why?
Gene Expression Regulation, Neoplastic
4
2021
1344
0.150
 Why?
Case-Control Studies
4
2020
3377
0.150
 Why?
Carcinoma, Ductal, Breast
2
2011
82
0.150
 Why?
CD8-Positive T-Lymphocytes
2
2018
857
0.140
 Why?
Androgen Receptor Antagonists
2
2017
36
0.140
 Why?
Exosomes
1
2019
96
0.140
 Why?
Neoplasm Recurrence, Local
3
2021
958
0.140
 Why?
Carcinosarcoma
1
2017
17
0.140
 Why?
Insulin-Like Growth Factor II
1
2017
25
0.140
 Why?
Insulin-Like Growth Factor Binding Protein 3
1
2017
39
0.140
 Why?
Motor Neurons
2
1990
236
0.140
 Why?
Tryptophan
1
2018
178
0.140
 Why?
Microfilament Proteins
1
2017
128
0.130
 Why?
Observer Variation
1
2017
315
0.130
 Why?
Uterine Neoplasms
1
2017
102
0.130
 Why?
Plant Extracts
1
2018
198
0.130
 Why?
Calcitriol
1
2016
55
0.120
 Why?
Antigens, CD
2
2015
489
0.120
 Why?
Endometrial Neoplasms
2
2008
164
0.120
 Why?
Maryland
1
2015
46
0.120
 Why?
CD8 Antigens
1
2015
76
0.120
 Why?
Leukocyte Common Antigens
1
2015
82
0.120
 Why?
Antigens, Differentiation, Myelomonocytic
1
2015
60
0.120
 Why?
Protein Tyrosine Phosphatases
1
2016
169
0.120
 Why?
Receptor, ErbB-2
1
2017
326
0.120
 Why?
Genotype
1
2020
1835
0.120
 Why?
Prostatitis
1
2014
18
0.120
 Why?
Phenotype
2
2024
3074
0.110
 Why?
Watchful Waiting
1
2015
67
0.110
 Why?
CD4 Antigens
1
2015
138
0.110
 Why?
Growth Differentiation Factor 15
1
2014
41
0.110
 Why?
Proteome
1
2019
438
0.110
 Why?
TOR Serine-Threonine Kinases
1
2017
396
0.110
 Why?
Randomized Controlled Trials as Topic
1
2020
1365
0.110
 Why?
Prostatic Intraepithelial Neoplasia
1
2013
12
0.110
 Why?
DNA-Binding Proteins
1
2021
1446
0.110
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
6
2010
12
0.110
 Why?
Carrier Proteins
1
2017
742
0.110
 Why?
Prognosis
4
2017
3773
0.110
 Why?
Androgen Antagonists
1
2014
79
0.100
 Why?
Endometrial Hyperplasia
3
2008
11
0.100
 Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2010
69
0.100
 Why?
Hindlimb
2
1990
122
0.100
 Why?
Chromatin
1
2016
478
0.100
 Why?
Benzamides
3
2021
207
0.100
 Why?
Nitriles
3
2021
172
0.100
 Why?
Apoptosis
5
2017
2499
0.100
 Why?
Muscle Denervation
2
1990
12
0.100
 Why?
Proteomics
1
2019
1054
0.100
 Why?
Receptors, Transferrin
1
2011
23
0.090
 Why?
Nephrectomy
1
2013
160
0.090
 Why?
Practice Patterns, Physicians'
1
2000
1267
0.090
 Why?
Nerve Regeneration
2
1990
62
0.090
 Why?
Neoplasm Staging
6
2017
1290
0.090
 Why?
Imaging, Three-Dimensional
2
2005
529
0.090
 Why?
Patient Selection
1
2015
662
0.090
 Why?
Female
23
2024
68556
0.090
 Why?
NF-kappa B
1
2014
665
0.090
 Why?
Brenner Tumor
1
2010
1
0.090
 Why?
Transcription Factors
2
2008
1647
0.080
 Why?
Cell Proliferation
4
2021
2375
0.080
 Why?
Papillomaviridae
1
2010
114
0.080
 Why?
Ischemia
1
2013
406
0.080
 Why?
Signal Transduction
2
2021
4926
0.080
 Why?
Prostatectomy
4
2013
106
0.080
 Why?
Polymerase Chain Reaction
2
2010
1036
0.080
 Why?
Risk Factors
5
2021
9746
0.070
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2017
1556
0.070
 Why?
Incidence
1
2015
2636
0.070
 Why?
Germinoma
1
2007
11
0.070
 Why?
Receptors, Steroid
1
2007
50
0.070
 Why?
Endoribonucleases
1
2007
73
0.070
 Why?
Muscles
1
1988
321
0.070
 Why?
Models, Anatomic
2
2004
89
0.070
 Why?
Testicular Neoplasms
1
2007
103
0.060
 Why?
DNA-Cytosine Methylases
1
2006
4
0.060
 Why?
Site-Specific DNA-Methyltransferase (Adenine-Specific)
1
2006
4
0.060
 Why?
Prostate-Specific Antigen
2
2018
162
0.060
 Why?
Histone Acetyltransferases
1
2006
61
0.060
 Why?
Kidney
1
2013
1385
0.060
 Why?
MCF-7 Cells
2
2016
116
0.060
 Why?
Anilides
2
2016
72
0.060
 Why?
Antineoplastic Agents
1
2016
2054
0.060
 Why?
Carcinoma, Pancreatic Ductal
1
2008
270
0.060
 Why?
Urological Agents
1
2024
3
0.060
 Why?
Lung Neoplasms
1
2017
2342
0.060
 Why?
Gene Frequency
1
2006
502
0.060
 Why?
Carcinoma, Lobular
1
2005
48
0.060
 Why?
Homeodomain Proteins
1
2008
495
0.060
 Why?
Uterine Cervical Neoplasms
1
2007
230
0.060
 Why?
Reactive Nitrogen Species
1
2004
22
0.060
 Why?
Adult
14
2015
35497
0.050
 Why?
Logistic Models
2
2021
1985
0.050
 Why?
Image Processing, Computer-Assisted
2
2005
742
0.050
 Why?
Prostaglandin-Endoperoxide Synthases
1
2004
73
0.050
 Why?
Tumor Suppressor Protein p53
1
2008
509
0.050
 Why?
Trans-Activators
1
2006
388
0.050
 Why?
Drug Resistance
1
2024
166
0.050
 Why?
Atrophy
2
2014
171
0.050
 Why?
Causality
1
2004
118
0.050
 Why?
Papillomavirus Infections
1
2007
297
0.050
 Why?
Cyclooxygenase 2
1
2004
177
0.050
 Why?
Isoenzymes
1
2004
302
0.050
 Why?
Sensitivity and Specificity
4
2010
1839
0.050
 Why?
Odds Ratio
2
2017
1019
0.050
 Why?
Carcinoma
1
2003
215
0.050
 Why?
DNA Damage
1
2004
383
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2004
530
0.040
 Why?
Reactive Oxygen Species
1
2004
596
0.040
 Why?
Bone and Bones
1
2024
295
0.040
 Why?
Developed Countries
1
2001
34
0.040
 Why?
Epidemiologic Studies
1
2001
65
0.040
 Why?
Multivariate Analysis
2
2017
1497
0.040
 Why?
Neoplasm Metastasis
2
2017
610
0.040
 Why?
Pancreatic Neoplasms
1
2008
881
0.040
 Why?
Autopsy
2
2013
92
0.040
 Why?
Tumor Microenvironment
1
2024
631
0.040
 Why?
Androgens
1
2021
178
0.040
 Why?
Statistics as Topic
1
2000
307
0.040
 Why?
Cell Nucleus
2
2016
586
0.040
 Why?
Cats
2
1990
207
0.040
 Why?
Physician Assistants
1
2000
89
0.040
 Why?
Fruit and Vegetable Juices
1
2018
15
0.040
 Why?
T-Lymphocytes
1
2007
1933
0.040
 Why?
Filamins
1
2019
27
0.040
 Why?
Tumor Necrosis Factor-alpha
1
2004
1202
0.040
 Why?
Molecular Imaging
1
2019
55
0.040
 Why?
Electric Stimulation
2
1990
269
0.040
 Why?
Nurse Practitioners
1
2000
132
0.040
 Why?
Cell Cycle
1
2021
589
0.040
 Why?
Gene Expression Profiling
1
2005
1688
0.040
 Why?
Pathologists
1
2017
17
0.040
 Why?
Mice
3
2024
16915
0.040
 Why?
Kynurenine
1
2018
114
0.040
 Why?
Tissue Array Analysis
2
2008
57
0.040
 Why?
Membrane Proteins
1
2004
1117
0.040
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2017
9
0.030
 Why?
Isometric Contraction
2
1990
187
0.030
 Why?
Everolimus
1
2017
88
0.030
 Why?
Animals
5
2024
35309
0.030
 Why?
Trastuzumab
1
2017
101
0.030
 Why?
Chromatography, Liquid
1
2019
424
0.030
 Why?
Cyclohexanes
1
2016
22
0.030
 Why?
DNA, Viral
2
2010
349
0.030
 Why?
Guideline Adherence
1
2000
526
0.030
 Why?
Socioeconomic Factors
1
2000
1209
0.030
 Why?
Cytokines
1
2004
2013
0.030
 Why?
Inflammation Mediators
1
2019
505
0.030
 Why?
Tandem Mass Spectrometry
1
2019
523
0.030
 Why?
Oncogenes
1
2016
112
0.030
 Why?
Gene Expression
1
2020
1466
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
193
0.030
 Why?
Gene Expression Regulation
1
2024
2537
0.030
 Why?
Computer Simulation
2
2013
939
0.030
 Why?
Receptors, Progesterone
2
2007
343
0.030
 Why?
Insulin-Like Growth Factor I
1
2017
307
0.030
 Why?
Sex Factors
1
2000
1965
0.030
 Why?
Xenograft Model Antitumor Assays
1
2017
812
0.030
 Why?
Tosyl Compounds
1
2014
16
0.030
 Why?
Neoplasm Grading
1
2015
283
0.030
 Why?
Blotting, Western
2
2007
1204
0.030
 Why?
Transplantation, Heterologous
1
2014
192
0.030
 Why?
Neoplasm Transplantation
1
2014
256
0.030
 Why?
Reproducibility of Results
2
2013
3080
0.030
 Why?
Binding Sites
1
2016
1250
0.030
 Why?
Estradiol
1
2016
494
0.030
 Why?
Cystatin C
1
2013
65
0.030
 Why?
Predictive Value of Tests
2
2008
1949
0.020
 Why?
Healthcare Disparities
1
2019
575
0.020
 Why?
Calcium
1
2019
1212
0.020
 Why?
Disease-Free Survival
1
2014
645
0.020
 Why?
Image Interpretation, Computer-Assisted
1
2013
253
0.020
 Why?
Treatment Outcome
2
2018
10202
0.020
 Why?
Nerve Endings
1
1990
5
0.020
 Why?
Creatinine
1
2013
491
0.020
 Why?
Histocytochemistry
1
1990
82
0.020
 Why?
Colorado
1
2000
4406
0.020
 Why?
Reperfusion Injury
1
2013
272
0.020
 Why?
CA-125 Antigen
1
2010
15
0.020
 Why?
Carcinoembryonic Antigen
1
2010
41
0.020
 Why?
Neurons
1
2019
1494
0.020
 Why?
Double-Blind Method
1
2014
1875
0.020
 Why?
Mutation
1
2020
3710
0.020
 Why?
Cross-Sectional Studies
1
2000
5051
0.020
 Why?
Up-Regulation
1
2011
839
0.020
 Why?
Zinc Finger E-box-Binding Homeobox 1
1
2008
24
0.020
 Why?
Prospective Studies
2
2013
7123
0.020
 Why?
Spinal Nerve Roots
1
1988
25
0.020
 Why?
Tissue Fixation
1
2008
34
0.020
 Why?
Surveys and Questionnaires
1
2000
5384
0.020
 Why?
Octamer Transcription Factor-3
1
2007
17
0.020
 Why?
Fluorescent Antibody Technique, Indirect
1
2007
48
0.020
 Why?
Biopsy, Fine-Needle
1
2008
68
0.020
 Why?
Immunoenzyme Techniques
1
2008
214
0.020
 Why?
Transcription Factor AP-2
1
2007
83
0.020
 Why?
CD3 Complex
1
2007
103
0.020
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2007
87
0.020
 Why?
Hysterectomy
1
2008
118
0.020
 Why?
Papanicolaou Test
1
2007
42
0.020
 Why?
Vaginal Smears
1
2007
55
0.020
 Why?
Gene Silencing
1
2008
190
0.020
 Why?
Diagnosis, Differential
1
2011
1432
0.020
 Why?
Organ Size
1
2008
446
0.020
 Why?
Genetic Linkage
1
2007
299
0.020
 Why?
Nuclear Receptor Coactivator 3
1
2006
6
0.020
 Why?
Alphapapillomavirus
1
2007
40
0.020
 Why?
Cadherins
1
2008
188
0.020
 Why?
Endosonography
1
2008
143
0.020
 Why?
Adolescent
2
2007
20315
0.020
 Why?
Adenocarcinoma, Clear Cell
1
2005
14
0.020
 Why?
Preoperative Care
1
2008
339
0.020
 Why?
Pancreas
1
2008
304
0.020
 Why?
Acute Kidney Injury
1
2013
790
0.010
 Why?
Protein Isoforms
1
2006
389
0.010
 Why?
Cystadenocarcinoma, Serous
1
2005
69
0.010
 Why?
Adenocarcinoma, Mucinous
1
2005
74
0.010
 Why?
Proto-Oncogene Proteins
1
2008
635
0.010
 Why?
Postmenopause
1
2006
350
0.010
 Why?
Breast
1
2005
153
0.010
 Why?
Cells, Cultured
1
2011
4077
0.010
 Why?
United States
1
2001
13828
0.010
 Why?
Ultrasonography
1
2007
713
0.010
 Why?
Pilot Projects
1
2008
1584
0.010
 Why?
Genetic Variation
1
2007
938
0.010
 Why?
Neoadjuvant Therapy
1
2005
381
0.010
 Why?
Time Factors
1
2013
6543
0.010
 Why?
Mitochondria
1
2008
877
0.010
 Why?
Antibodies, Monoclonal
1
2007
1367
0.010
 Why?
RNA, Messenger
1
2008
2703
0.010
 Why?
Young Adult
1
2015
12392
0.010
 Why?
Follow-Up Studies
1
2007
4887
0.010
 Why?
Neoplasms
1
2007
2449
0.010
 Why?
Retrospective Studies
1
2008
14461
0.010
 Why?
Torkko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (290) concept(s)
_
Co-Authors Expand Description
See all (33) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)